Potassium abnormalities in current clinical practice: Frequency, causes, severity and management

Medical Principles and Practice

Volumn 24, Issue 3, 2015, Pages 271-275

  Eliacik, Eylem ^a   Yildirim, Tolga ^b   Sahin, Ugur ^a   Kizilarslanoglu, Cemal ^a   Tapan, Umit ^a   Aybal Kutlugun, Aysun ^b   Hascelik, Gulsen ^a   Arici, Mustafa ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Departments of Nephrology   (Turkey)

Author keywords

Hyperkalemia; Hypokalemia; Potassium

Indexed keywords

ALDOSTERONE ANTAGONIST; CATECHOLAMINE; DIURETIC AGENT; ELECTROLYTE; GLUCOSE; INSULIN; MAGNESIUM; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM; SALBUTAMOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYDRATION; HYPERKALEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; INSULIN TREATMENT; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; POTASSIUM DEFICIENCY; POTASSIUM DEPLETION; PREVALENCE; VOMITING; AGED; COMPLICATION; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; TURKEY; UNIVERSITY HOSPITAL;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; HYPERKALEMIA; HYPOKALEMIA; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; TURKEY;

EID: 84929961695     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000376580     Document Type: Article

References (24)

1. Palmer BF, Dubose TD Jr: Disorder of potassium metabolism; in Schrier RW (ed): Renal and Electrolyte Disorders, ed 7. Philadelphia, Wolters Kluwer/Lippincott Williams and Wilkins, 2010, pp 137-166.
2. Rose BD, Post TW: Clinical Physiology of Acid-Base and Electrolyte Disorders, ed 5. New York, McGraw-Hill, 2001, pp 836-857.
3. Gennari FJ: Hypokalemia. N Engl J Med 1998; 339: 451-458.
4. Squires RD, Huth EJ: Experimental potassium depletion in normal human subjects. I. Relation of ionic intakes to the renal conservation of potassium. J Clin Invest 1959; 38: 1134-1148.
5. Stanton BA: Renal potassium transport: morphological and functional adaptation. Am J Physiol 1989; 257:R989-R997.
6. Alfonzo AV, Isles C, Geddes C, et al: Potassium disorders-clinical spectrum and emergency management. Resuscitation 2006; 70: 10-25.
7. Cohn JN, Kowey PR, Whelton PK, et al: New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. Arch Intern Med 2000; 160: 2429-2436.
8. Hoskote SS, Joshi SR, Ghosh AK: Disorders of potassium homeostasis: pathophysiology and management. J Assoc Physicians India 2008; 56: 685-693.
9. Morgan DB, Davidson C: Hypokalaemia and diuretics: an analysis of publications. Br Med J 1980; 280: 905-908.
10. Acker CG, Johnson JP, Palevsky PM, et al: Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 1998; 158: 917-924.
11. Crop MJ, Hoorn EJ, Lindemas J, et al: Hypokalemia and subsequent hyperkalemia in hospitalized patients. Nephrol Dial Transplant 2007; 22: 3471-3477.
12. Paice BJ, Paterson KR, Onyanga-Omara F, et al: Record linkage study of hypokalaemia in hospitalized patients. Postgrad Med J 1986; 62: 187-191.
13. Byatt CM, Millard PH, Levin GE: Diuretics and electrolyte disturbances in 1, 000 consecutive geriatric admissions. J R Soc Med 1990; 83: 704-708.
14. Rose BD, Post TW: Clinical Physiology of Acid-Base and Electrolyte Disorders, ed 5. New York, McGraw-Hill, 2001, pp 857-863.
15. Morell V, Lundgren E, Gillott A: Predicting severity of trauma by admission white blood cell count, serum potassium level, and arterial pH. South Med J 1993; 86: 658-659.
16. Bozkurt B, Agoston I, Knowlton AA: Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines. J Am Coll Cardiol 2003; 41: 211-214.
17. Georges B, Beguin C, Jadoul M: Spironolactone and congestive heart-failure. Lancet 2000; 355: 1369-1370.
18. Reardon LC, Macpherson DS: Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry Arch Intern Med 1998; 158: 26-32.
19. Ahuja TS, Freeman D Jr, Mahnken JD, et al: Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors. Am J Nephrol 2000; 20: 268-272.
20. Rimmer JM, Horn JF, Gennari FJ: Hyperkalemia as a complication of drug therapy. Arch Intern Med 1987; 147: 867-869.
21. Perazella MA: Drug-induced hyperkalemia: old culprits and new offenders. Am J Med 2000; 109: 307-314.
22. Yildirim T, Arici M, Piskinpasa S, et al: Major barriers against renin-angiotensin-aldosterone system blocker use in chronic kidney disease stages 3-5 in clinical practice: a safety concern Ren Fail 2012; 34: 1095-1099.
23. Ciorba A, Bovo R, Castiglione A, Pirodda A, Martini A: Sudden bilateral sensorineural hearing loss as an unusual consequence of accidental ingestion of potassium hydroxide. Med Princ Pract 2010; 19: 406-408.
24. DeVita MV, Han H, Chan R, et al: Drug use and elderly in relation to changing etiologies of hyperkalemia. Geriatr Nephrol Urol 1991; 1: 41-45.